FDA recall, , Moderate risk
LifeShare Blood Center Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were collected from a donor who was a resident of a malaria endemic area.
Recall ended Aug 10, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeShare Blood Center began a recall of Red Blood Cells, Leukocytes Reduced on September 22, 2025, because the product was collected from a donor who was a resident of a malaria endemic area, according to the FDA. The recall was added to the FDA's Enforcement Report and classified on August 10, 2026, and was in the FDA's weekly enforcement report on August 19, 2026. The distributed product was in Louisiana.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- LifeShare Blood Center
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99416
- Recall number
- B-0157-2026
All recalls from LifeShare Blood Center
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
